Abstract X linked hereditary spastic paraplegia is a rare condition that has been divided into two forms (the pure spastic form and the complicated form) as a function of clinical course and severity. A gene for pure hereditary spastic paraplegia (SPG2) has been mapped to the proximal long arm of the X chromosome (Xq2l) by linkage to the DXS1 7 locus, while a gene for a complicated form of the disease has been mapped to the distal long arm by linkage to the DXS52 locus (Xq28).
Abstract X linked hereditary spastic paraplegia is a rare condition that has been divided into two forms (the pure spastic form and the complicated form) as a function of clinical course and severity. A gene for pure hereditary spastic paraplegia (SPG2) has been mapped to the proximal long arm of the X chromosome (Xq2l) by linkage to the DXS1 7 locus, while a gene for a complicated form of the disease has been mapped to the distal long arm by linkage to the DXS52 locus (Xq28).
Here we report on the mapping of a gene for complicated hereditary spastic paraplegia to the Xq21 region by linkage to the probe S9 at the DXS1 7 locus (Z = 5 at 0 = 004) in a three generation pedigree. Multipoint linkage analysis supports the distal location of the disease gene with respect to the DXYSI-DXS1 7 block (cen-DXYS1-DXS3-DXS1 7-SPG2-tel).
The observation of a complicated form of spastic paraplegia mapping to Xq2l raises the difficult issue of variable phenotypic expression, allelic heterogeneity, or even close proximity of two genes for hereditary spastic paraplegia in this region. However, since our study provides clinical evidence for intrafamilial heterogeneity in complicated X linked spastic paraplegia, the present data support the hypothesis of variable clinical expression of a single gene at the SPG2 locus, as previously suggested for SPG1. Finally, we report here what we believe to be the first evidence of clinical expression in heterozygous carriers, a feature that is relevant to genetic counselling in at risk females.
(J Med Genet 1993;30:381-4) X linked hereditary spastic paraplegia (HSP) is a rare condition whose clinical heterogeneity has long been recognised.' While pure spasticity of the lower limbs has been reported in 2 3 some pedigrees, most patients reported were found to display a more complicated neurological profile including cerebellar ataxia, sensory loss, nystagmus, optic atrophy, congenital malformations, and mental retardation. Figure I Pedigree offamily. paresis, and leg muscle wasting at 22 years of age.
Methods
Total DNA was extracted from circulating leucocytes, digested using restriction enzymes, and submitted to gel electrophoresis for Southern blotting. Membranes were hybridised using 12P-dCTP labelled DNA probes at the polymorphic loci DXYSI (probe pDP34), DXS3 (probe p19.2), DXS287 (probe pYNH3), DXS1 7 (probe S9), and DXS52 (probe Stl4)."1 Linkage analysis was performed on a personal computer using the LINKAGE program version 4.9. Pairwise lod scores were calculated using the MLINK option.'2 Multipoint linkage analysis was performed using the LINKMAP program." Genetic distances between markers were obtained from a previous study. '4 Results A total of 35 subjects including 10 affected males, seven healthy males born to heterozygous mothers, five obligate carriers, and 13 relatives were tested. Table 3 shows the pairwise lod scores between the disease locus and loci DXYS1, DXS3, DXS17, and DXS52. The maximum lod score value (Z= 5 at 0 = 0-04) was obtained with probe S9 at locus DXS1 7 (Xq2 1 .3-q22) .
Positive lod score values were also obtained with two other polymorphic probes for the q2 1 region, namely P19.2 and pDP34 at loci DXS3 and DXYSI respectively (table 3) . Probe pYNH3 at locus DXS287 was not informative. Two recombination events were observed in subjects III.9 and III.13 (fig 1) . In subject III.9 (a female expressing the disease) recombination occurred between DXYSI and DXS3-DXS17. In subject III. 13 (an affected male) recombination occurred between DXS3 and DXS1 7.
Negative lod score values were obtained with probe Stl4 excluding the disease from close proximity to the DXS52 locus (Z =-2 at 0= 0. 12). Second, this study gives additional support to the variable expression of the disease gene among affected subjects. Indeed, a broad spectrum of clinical phenotypes was observed in affected males, ranging from severe spasticity with nystagmus, cerebellar syndrome, and mental retardation to mild pyramidal tract involvement with normal gait and intelligence. This intrafamilial heterogeneity has been previously noted by Johnston and McKusick in a large pedigree of 17 affected males in whom spastic paraplegia was associated, to various degrees, with sensory loss, nystagmus, optic atrophy, dysarthria, and mental retardation.5 Similarly, Goldblatt et a19 reported variable phenotypes of X linked HSP in a large kindred in which pyramidal signs were associated with nystagmus, optic atrophy, mild ataxia of the arms, and intellectual impairment. Our family manifests a complicated X linked HSP very similar to that described by Johnston and McKusick5 and Goldblatt et a19 and it appears therefore that clinical heterogeneity is a consistent feature in this form of X linked spastic paraplegia.
Finally, the present study establishes linkage of the disease gene to the DXS17 locus (Z = 5 at 0 = 0-04) in one single family and gives additional support to the presence of a gene for complicated HSP on the proximal long arm of the X chromosome (Xq21 
